Collectively, these findings underscore the mechanistic role of miR-375 in modulating insulin signaling pathways at the molecular level and highlight GLUT4 mRNA expression as a potential downstream marker of therapeutic success in miRNA-based interventions for T2DM. Here, SLC2A4 is linked to type 2 diabetes mellitus.